title: Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable?
authors.forename: Sarah
authors.initials: S
authors.lastname: Kidd
authors.forename: Robert
authors.initials: R
authors.lastname: Kirkcaldy
authors.forename: Hillard
authors.initials: H
authors.lastname: Weinstock
authors.forename: Gail
authors.initials: G
authors.lastname: Bolan
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D020682:Cefixime / Q000494:pharmacology; D002443:Ceftriaxone / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000472:pathogenicity; D011634:Public Health / Q000331:legislation & jurisprudence; D017211:Treatment Failure
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D020682:Cefixime